https://socictopen.socict.org/files/original/6f917bf8733c8ef9c68d7e2f1fce21e2.pdf 794ff0ade838759e0bd9b6b8c45a90a1 Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Coronavirus Description An account of the resource Dominio científico: Coronavirus Text A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text. Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource SARS Antibody Test for Serosurveillance Creator An entity primarily responsible for making the resource Po-Ren Hsueh, Chuan-Liang Kao, Cun-Nan Lee, Li-Kuan Chen, Mei-Shian Ho, Charles Sia, Xin De Fang, Shugene Lynn, Tseng Yuan Chang, Shi Kau Liu, Alan M. Walfield, Changyi Wang Description An account of the resource A peptide-based enzyme-linked immunosorbent assay (ELISA) can be used for retrospective serosurveillance of severe acute respiratory syndrome (SARS) by helping identify undetected chains of disease transmission. The assay was developed by epitope mapping, using synthetic peptides from the spike, membrane, and nucleocapsid protein sequences of SARS-associated coronavirus. The new peptide ELISA consistently detected seroconversion by week 2 of onset of fever, and seropositivity remained through day 100. Specificity was 100% on normal blood donor samples, on serum samples associated with infection by other pathogens, and on an interference panel. The peptide-based test has advantages of safety, standardization, and automation over previous immunoassays for SARS. The assay was used for a retrospective survey of healthy healthcare workers in Taiwan who treated SARS patients. Asymptomatic seroconversions were detected in two hospitals that had nosocomial disease. Date A point or period of time associated with an event in the lifecycle of the resource 2004 Subject The topic of the resource research, SARS-CoV, serologic test, Enzyme-Linked Immunosorbent Assay, synthetic peptide, S protein Identifier An unambiguous reference to the resource within a given context DOI: 10.3201/eid1009.040101 Source A related resource from which the described resource is derived Emerging Infectious Diseases Publisher An entity responsible for making the resource available Centers for Disease Control and Prevention Coverage The spatial or temporal topic of the resource, the spatial applicability of the resource, or the jurisdiction under which the resource is relevant Infectious and parasitic diseases, Medicine Language A language of the resource EN